Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-10

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (KVK-TECH, INC)

View source ↗

Summary

FDA approved a supplemental application for Dexmethylphenidate hydrochloride from KVK-Tech, Inc., granting approval of a generic product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmethylphenidate hydrochloride (generic) (dexmethylphenidate hydrochloride)

Snippet

SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)